» Authors » Gordon Watson

Gordon Watson

Explore the profile of Gordon Watson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 164
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Morrall Z, Preston J, Richier S, Franklin D, Lamb A, Olivier A, et al.
Mar Pollut Bull . 2025 Mar; 214:117747. PMID: 40054310
Driven by eutrophic conditions, AM (algal mat) proliferation is now ubiquitous in coastal areas generating significant ecological and economic impacts. The need to mitigate negative effects has prompted the exploration...
2.
Agrawal N, Shireman J, Shiue K, Kamer A, Boyd L, Zang Y, et al.
Neurooncol Pract . 2024 Sep; 11(5):593-603. PMID: 39279766
Background: Stereotactic radiosurgery (SRS) following surgical resection is the standard of care for patients with symptomatic oligo brain metastasis (BM), however, it is associated with 10-15% local failure. Targeting a...
3.
Shireman J, White Q, Ni Z, Mohanty C, Cai Y, Zhao L, et al.
iScience . 2024 Apr; 27(4):109601. PMID: 38623341
Stereotactic radiosurgery (SRS) has been shown to be efficacious for the treatment of limited brain metastasis (BM); however, the effects of SRS on human brain metastases have yet to be...
4.
OShea R, Capuzzo E, Hemming V, Grebe G, Stafford R, van den Burg S, et al.
J Environ Manage . 2024 Apr; 358:120696. PMID: 38614003
The offshore Multi-use Setting (MUS) is a concept that aims to co-locate marine industrial activities, including wind farms and aquaculture. MUS is considered an innovative approach to promoting efficiency in...
5.
Shireman J, White Q, Agrawal N, Ni Z, Chen G, Zhao L, et al.
medRxiv . 2023 May; PMID: 37131583
Stereotactic Radiosurgery (SRS) is one of the leading treatment modalities for oligo brain metastasis (BM), however no comprehensive genomic data assessing the effect of radiation on BM in humans exist....
6.
Budnick H, Richardson A, Shiue K, Watson G, Ng S, Le Y, et al.
Cureus . 2021 Dec; 13(11):e19390. PMID: 34925992
GammaTile® (GT Medical Technologies, Tempe, Arizona) is a surgically targeted radiation source, approved by FDA for brachytherapy in primary and secondary brain neoplasms. Each GammaTile is composed of a collagen...
7.
Liu Y, Wang W, Shiue K, Yao H, Cerra-Franco A, Shapiro R, et al.
Radiother Oncol . 2020 Oct; 156:231-238. PMID: 33096168
Background And Purpose: Radiation pneumonitis (RP) can be a potential fatal toxicity of stereotactic body radiation therapy (SBRT) for medically inoperable non-small cell lung cancer (NSCLC). This study aimed to...
8.
Mohammadi H, Shiue K, Grass G, Verma V, Engellandt K, Daubner D, et al.
Neurooncol Pract . 2020 Jul; 7(2):185-195. PMID: 32626587
Background: Pseudoprogression (psPD) represents false radiologic evidence of tumor progression and is observed in some glioblastoma (GBM) patients after postoperative chemoradiation (CRT) with temozolomide (TMZ). The ambiguity of the psPD...
9.
Huff W, Agrawal N, Shapiro S, Miller J, Kulwin C, Shah M, et al.
Radiat Oncol . 2018 Dec; 13(1):252. PMID: 30572923
Background: Stereotactic radiosurgery (SRS) has emerged as a common adjuvant modality used with surgery for resectable brain metastases (BMs). However, the optimal sequence of the multi-modality therapy has not been...
10.
Shiue K, Cerra-Franco A, Shapiro R, Estabrook N, Mannina E, Deig C, et al.
J Thorac Oncol . 2018 Jul; 13(10):1549-1559. PMID: 29959060
Introduction: It remains unclear if histology should be independently considered when choosing stereotactic ablative body radiotherapy dose prescriptions for NSCLC. Methods: The study population included 508 patients with 561 lesions...